5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc; 2022. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu. Accessed May 17th, 2022.
  2. IBM Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu/  (cited: May 17th, 2022).
  3. Ciprofloxacin tablets (Cipro®) package insert. Bayer Healthcare Pharmaceuticals, Inc., November 2021.
  4. Ciprofloxacin extended-release tablets (Cipro® XR) package insert. Mylan Pharmaceuticals, Inc., May 2019.
  5. Delafloxacin tablets (Baxdela®) package insert. Melinta Therapeutics, LLC. June 2021.
  6. Gemifloxacin tablets (Factive®) package insert. Merus Labs International, Inc., August 2016.
  7. Levofloxacin tablets (Levaquin®) package insert. Cipla USA Inc., July 2020.
  8. Moxifloxacin tablets (Avelox®) package insert. Bayer Healthcare Pharmaceuticals Inc., July 2016.
  9. Ofloxacin tablets package insert. Dr. Reddy’s Laboratories Limited, December 2018.
  10. Jackson MA, Schutze GE, for the Committee on Infectious Diseases. The use of systemic and topical fluoroquinolones. Pediatrics. 2016;138(5):e1-e13 (doi: 10.1542/peds.2016-2706).